|
KIF2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28759999999495E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.213100E-04 |
| Normal-vs-Stage2 |
3.182300E-04 |
| Normal-vs-Stage3 |
1.173130E-04 |
| Normal-vs-Stage4 |
4.030700E-04 |
| Stage1-vs-Stage2 |
3.354800E-01 |
| Stage1-vs-Stage3 |
5.335200E-01 |
| Stage1-vs-Stage4 |
4.851200E-01 |
| Stage2-vs-Stage3 |
6.344800E-01 |
| Stage2-vs-Stage4 |
8.143200E-01 |
| Stage3-vs-Stage4 |
8.301600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.022100E-04 |
| Normal-vs-AfricanAmerican |
2.969800E-02 |
| Normal-vs-Asian |
3.182300E-04 |
| Caucasian-vs-AfricanAmerican |
8.167800E-01 |
| Caucasian-vs-Asian |
3.546200E-01 |
| AfricanAmerican-vs-Asian |
4.092000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3333999999986E-05 |
| Normal-vs-Female |
8.26770000000865E-05 |
| Male-vs-Female |
2.479200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.222200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.16830000002266E-06 |
| Normal-vs-Age(61-80Yrs) |
8.20750000000148E-05 |
| Normal-vs-Age(81-100Yrs) |
1.275160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.211770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.307600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.792200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.552000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.185800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.542800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.872400E-01 |
| Classical-VS-Follicular |
1.93445999999708E-05 |
| Classical-VS-Other |
4.358400E-02 |
| Classical-VS-Normal |
2.082500E-03 |
| Tall-VS-Follicular |
3.737600E-02 |
| Tall-VS-Other |
9.674200E-02 |
| Tall-VS-Normal |
1.147500E-02 |
| Follicular-VS-Other |
5.326600E-01 |
| Follicular-VS-Normal |
1.23700000242977E-08 |
| Other-VS-Normal |
1.681780E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.68419999969328E-07 |
| Normal-vs-N1 |
5.87739999999837E-05 |
| N0-vs-N1 |
6.573400E-01 |
|
|
